FDA panel to focus on safety of Novartis gene therapy drug – WHTC
WHTC |
FDA panel to focus on safety of Novartis gene therapy drug
WHTC (Reuters) – The U.S. Food and Drug Administration will ask a panel of advisors to focus on the safety of Novartis AG's experimental gene therapy drug when it meets to review the leukemia treatment on Wednesday. The keenly anticipated preliminary review … |
